EdiGene Raises Approximately USD 62 Million in Series B Plus Financing and Expands Operation Locations to Advance and Scale Up Clinical Translation of Gene Editing Technologies
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--EdiGene, Inc. (“Company”, or “EdiGene”), today announced the successful completion of an RMB 400 million (approximately...






